Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease.

GigaScience - 1 Jul 2018

Zhang Hongjiu, Zhu Fan, Dodge Hiroko H, Higgins Gerald A, Omenn Gilbert S, Guan Yuanfang

Abstract excerpt

Motivation: Heterogeneous diseases such as Alzheimer's disease (AD) manifest a variety of phenotypes among populations. Early diagnosis and effective treatment offer cost benefits. Many studies on biochemical and imaging markers have shown potential promise in improving diagnosis, yet establishing quantitative diagnostic criteria for ancillary tests remains challenging. Results: We have developed a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognition Disorders
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Computer-Assisted

Share to Machine Learning

Share to Medical Informatics

Share to Normal Distribution

Share to Principal Component Analysis

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 30010762
DOI: 10.1093/gigascience/giy085
PMCID: PMC6054197

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease.PMID 30010762Read ↗

Identification and Validation of New Molecular Subtypes within the Early and Late Mild Cognitive Impairment Stages of Alzheimer’s DiseaseSemantic proximity Read ↗

Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationSemantic proximity Read ↗

Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationSemantic proximity Read ↗

Machine Learning-Based Multiclass Classification of Cognitive Stages Using Plasma Biomarkers, Clinical Assessments, and Genetic Features: A Repeated Nested Cross-Validation Study in ADNI with External Validation in CNTNSemantic proximity Read ↗

Subtyping Alzheimer's disease and Parkinson's disease using longitudinal electronic health records.Semantic proximity Read ↗

Molecular Subtyping of Mild Cognitive Impairment based on Genetic Polymorphism and Gene ExpressionSemantic proximity Read ↗

Multi-‘Omic Integration via Similarity Network Fusion to Detect Molecular Subtypes of AgingSemantic proximity Read ↗

ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.Semantic proximity Read ↗

Identifying progression subphenotypes of Alzheimer's disease from large-scale electronic health records with machine learning.Semantic proximity Read ↗

ANMerge: A comprehensive and accessible Alzheimer’s disease patient-level datasetSemantic proximity Read ↗

Deep learning-driven risk-based subtyping of cognitively impaired individualsSemantic proximity Read ↗

Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.